Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Multiparameter flow cytometry and ClonoSEQ correlation to evaluate precursor B-lymphoblastic leukemia measurable residual disease.

The study correlated Children's Oncology Group flow cytometry with clonoSEQ for measurable residual disease in precursor B-lymphoblastic leukemia.

Journal of HematopathologyPubMed 38175444DOI 10.1007/s12308-023-00544-9